Home › Post-COVID Conditions (Long COVID) › District of Columbia
Post-COVID Conditions (Long COVID) clinical trials in District of Columbia
4 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Georgetown University Medical Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Georgetown University Medical Center, Washington D.C.
- Emerson Clinical Research Institute, Washington D.C.
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
- Children's National Hospital, Washington D.C.
RecruitingPhase 1
Ages 2 to 80 · All sexes · Updated Mar 12, 2026 · NCT05141058From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.